semaglutide overdose death in a Diabetic Patient: Suicidal Behavior and Multiorgan Failure Semaglutide Overdose Risk: Safety Facts

As the report observes, M&A may be playing a relatively greater role given some pharmas need to replace genericising blockbusters. The first half of 2024 saw close to $100 billion worth of Big Pharma M&A, putting this year on track to surpass 2023 itself one of the top-three strongest M&A years in two decades

Risks include nausea, cardiovascular effects, priapism (prolonged erection requiring emergency care), skin changes, and unknown long-term effects

van Bennekum, A

However, its important that if you have a personal history or first degree relative with a history of c-cell thyroid tumor or multiple endocrine neoplasia, type two that you discuss this with your provider as these may not be a good medication choice for you